{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:19:02Z","timestamp":1784071142353,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12884-018-2058-9","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T09:20:04Z","timestamp":1540459204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12\u00a0months after initiating option B+"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-0139","authenticated-orcid":false,"given":"Pascal N.","family":"Atanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison T.","family":"Ndetan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Fon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry D.","family":"Meriki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tih P.","family":"Muffih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Achidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoelscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kroidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"issue":"6","key":"2058_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1001\/jama.296.6.679","volume":"296","author":"EJ Mills","year":"2006","unstructured":"Mills EJ, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Jama. 2006;296(6):679\u201390.","journal-title":"Jama"},{"issue":"Supplement_3","key":"2058_CR2","doi-asserted-by":"publisher","first-page":"S272","DOI":"10.1086\/533415","volume":"197","author":"DR Bangsberg","year":"2008","unstructured":"Bangsberg DR, Preventing HIV. Antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197(Supplement_3):S272\u20138.","journal-title":"J Infect Dis"},{"key":"2058_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12879-015-0914-z","volume":"15","author":"M Ngarina","year":"2015","unstructured":"Ngarina M, et al. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus study, Dar Es Salaam, Tanzania. BMC Infect Dis. 2015;15:175.","journal-title":"BMC Infect Dis"},{"key":"2058_CR4","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: summary of key features and recommendations. June. 2013:2013."},{"key":"2058_CR5","unstructured":"WHO, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing hiv infection: Recommendations for a Public Health approach. 2016."},{"issue":"1","key":"2058_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2325957413510607","volume":"14","author":"SE Takow","year":"2013","unstructured":"Takow SE, et al. Time for option B+? Prevalence and characteristics of HIV infection among attendees of 2 antenatal clinics in Buea, Cameroon. Journal of the International Association of Providers of AIDS Care. 2013;14(1):77\u201381.","journal-title":"Journal of the International Association of Providers of AIDS Care"},{"key":"2058_CR7","unstructured":"CDC. Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011\u2013September 2012. MMWR Morb Mortal Wkly Rep. 2013, 62(8):148."},{"issue":"2","key":"2058_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/tmi.12816","volume":"22","author":"PN Atanga","year":"2016","unstructured":"Atanga PN, et al. Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating \u2018option B+\u2018in the south west region. Tropical Med Int Health. 2016;22(2):161\u201370.","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"2058_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4102\/sajhivmed.v14i1.94","volume":"14","author":"A Coutsoudis","year":"2013","unstructured":"Coutsoudis A, et al. Is option B+ the best choice?: forum. Southern Afr J HIV Med. 2013;14(1):8\u201310.","journal-title":"Southern Afr J HIV Med"},{"issue":"4","key":"2058_CR10","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/S2352-3018(16)00008-4","volume":"3","author":"AD Haas","year":"2016","unstructured":"Haas AD, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi\u2019s option B+ programme: an observational cohort study. Lancet HIV. 2016;3(4):e175\u201382.","journal-title":"Lancet HIV"},{"issue":"4","key":"2058_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/QAD.0000000000000143","volume":"28","author":"L Tenthani","year":"2014","unstructured":"Tenthani L, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS (London, England). 2014;28(4):589\u201398.","journal-title":"AIDS (London, England)"},{"key":"2058_CR12","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1097\/QAI.0000000000000355","volume":"67","author":"NC Rollins","year":"2014","unstructured":"Rollins NC, et al. Defining and analyzing retention-in-care among pregnant and breastfeeding HIV-infected women: unpacking the data to interpret and improve PMTCT outcomes. J Acquir Immune Defic Syndr. 2014;67:S150\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2058_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijid.2014.12.026","volume":"33","author":"H Ebuy","year":"2015","unstructured":"Ebuy H, Yebyo H, Alemayehu M. Adherence level to and predictors of option B+ PMTCT program in Tigray, northern Ethiopia. Int J Infect Dis. 2015;33:123\u20139.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"2058_CR14","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/cid\/ciw500","volume":"63","author":"AD Haas","year":"2016","unstructured":"Haas AD, et al. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program. Clin Infect Dis. 2016;63(9):1227\u201335.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2058_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/01.qai.0000147522.34369.12","volume":"38","author":"PT Nieuwkerk","year":"2005","unstructured":"Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38(4):445\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"2058_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1258\/0956462042563666","volume":"15","author":"MM Kitahata","year":"2004","unstructured":"Kitahata MM, et al. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS. 2004;15(12):803\u201310.","journal-title":"Int J STD AIDS"},{"issue":"Suppl 1","key":"2058_CR17","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","volume":"43","author":"KM Berg","year":"2006","unstructured":"Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"2058_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/aid.2015.0065","volume":"32","author":"J Fokam","year":"2016","unstructured":"Fokam J, et al. Short communication: population-based surveillance of HIV-1 drug resistance in Cameroonian adults initiating antiretroviral therapy according to the World Health Organization guidelines. AIDS Res Hum Retrovir. 2016;32(4):329\u201333.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"2058_CR19","doi-asserted-by":"publisher","first-page":"20662","DOI":"10.7448\/IAS.19.1.20662","volume":"19","author":"I Mitiku","year":"2016","unstructured":"Mitiku I, et al. Factors associated with loss to follow-up among women in option B+ PMTCT programme in Northeast Ethiopia: a retrospective cohort study. J Int AIDS Soc. 2016;19(1):20662.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"2058_CR20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/tmi.12369","volume":"19","author":"H Tweya","year":"2014","unstructured":"Tweya H, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in option B+ PMTCT programme in Lilongwe, Malawi. Tropical Med Int Health. 2014;19(11):1360\u20136.","journal-title":"Tropical Med Int Health"},{"key":"2058_CR21","volume-title":"90\u201390-90: an ambitious treatment target to help end the AIDS epidemic","author":"UNAIDS","year":"2014","unstructured":"UNAIDS. 90\u201390-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014."},{"issue":"7","key":"2058_CR22","doi-asserted-by":"publisher","first-page":"e2783","DOI":"10.1371\/journal.pone.0002783","volume":"3","author":"J-J Parienti","year":"2008","unstructured":"Parienti J-J, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783.","journal-title":"PLoS One"},{"issue":"3","key":"2058_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1345\/aph.1P587","volume":"45","author":"AB Kobin","year":"2011","unstructured":"Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372\u20139.","journal-title":"Ann Pharmacother"},{"issue":"15","key":"2058_CR24","doi-asserted-by":"publisher","first-page":"e3361","DOI":"10.1097\/MD.0000000000003361","volume":"95","author":"Woldesellassie M. Bezabhe","year":"2016","unstructured":"Bezabhe WM, et al. Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Medicine. 2016;95(15).","journal-title":"Medicine"},{"key":"2058_CR25","volume-title":"National Guidelines on Taskshifting for the Management of HIV\/AIDS","author":"MOPH","year":"2016","unstructured":"MOPH. National Guidelines on Taskshifting for the Management of HIV\/AIDS. Yaounde: Cameroon Ministry of Public Health; 2016."},{"key":"2058_CR26","unstructured":"CNLS, Directives nationales des prevention et de prise en charge du VIH au Cameroon. National Guidelines, 2015."},{"key":"2058_CR27","volume-title":"Development of a multi-method tool to measure ART adherence in resource-constrained settings: the South Africa experience","author":"G Steel","year":"2007","unstructured":"Steel, G., J. Nwokike, and M.P. Joshi, Development of a multi-method tool to measure ART adherence in resource-constrained settings: the South Africa experience. RPM Plus, 2007."},{"issue":"1","key":"2058_CR28","first-page":"10","volume":"118","author":"G Vinten","year":"1998","unstructured":"Vinten G. Taking the threat out of threatening questions. J R Soc Promot Heal. 1998;118(1):10\u20134.","journal-title":"J R Soc Promot Heal"},{"issue":"2","key":"2058_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00126334-200402010-00016","volume":"35","author":"G Wagner","year":"2004","unstructured":"Wagner G, Miller LG. Is the influence of social desirability on patients' self-reported adherence overrated? J Acquir Immune Defic Syndr. 2004;35(2):203\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2058_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00002030-200201250-00017","volume":"16","author":"JC Walsh","year":"2002","unstructured":"Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. Aids. 2002;16(2):269\u201377.","journal-title":"Aids"},{"key":"2058_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1310\/JFXH-G3X2-EYM6-D6UG","volume":"5","author":"TP Giordano","year":"2004","unstructured":"Giordano TP, et al. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74\u20139.","journal-title":"HIV Clin Trials"},{"issue":"1","key":"2058_CR32","doi-asserted-by":"publisher","first-page":"17994","DOI":"10.7448\/IAS.16.1.17994","volume":"16","author":"P Ayuo","year":"2013","unstructured":"Ayuo P, et al. Frequency and factors associated with adherence to and completion of combination antiretroviral therapy for prevention of mother to child transmission in western Kenya. J Int AIDS Soc. 2013;16(1):17994.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"2058_CR33","first-page":"238","volume":"2","author":"A Igwegbe","year":"2010","unstructured":"Igwegbe A, Ugboaja J, Nwajiaku L. Prevalence and determinants of non-adherence to antiretroviral therapy among HIV-positive pregnant women in Nnewi, Nigeria. Int J Med Med Sci. 2010;2(8):238\u201345.","journal-title":"Int J Med Med Sci"},{"issue":"3","key":"2058_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10461-006-9078-6","volume":"10","author":"JM Simoni","year":"2006","unstructured":"Simoni JM, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227\u201345.","journal-title":"AIDS Behav"},{"issue":"5","key":"2058_CR35","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1097\/00126334-200408150-00014","volume":"36","author":"JH Oyugi","year":"2004","unstructured":"Oyugi JH, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36(5):1100\u20132.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2058_CR36","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1097\/QAI.0000000000001343","volume":"75","author":"L Myer","year":"2017","unstructured":"Myer L, et al. Beyond \u201coption B+\u201d: understanding antiretroviral therapy (ART) adherence, retention in care and engagement in ART Services among pregnant and postpartum women initiating therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2017;75:S115\u201322.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2058_CR37","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1097\/QAI.0000000000000263","volume":"67","author":"K Clouse","year":"2014","unstructured":"Clouse K, et al. \u201cWhat they wanted was to give birth; nothing else\u201d: barriers to retention in option B+ HIV care among postpartum women in South Africa. J Acquir Immune Defic Syndr. 2014;67(1):e12\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"2058_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002183","volume":"13","author":"Z Shubber","year":"2016","unstructured":"Shubber Z, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183.","journal-title":"PLoS Med"},{"issue":"2","key":"2058_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149527","volume":"11","author":"MH Kim","year":"2016","unstructured":"Kim MH, et al. Why did I stop? Barriers and facilitators to uptake and adherence to ART in option B+ HIV care in Lilongwe, Malawi. PLoS One. 2016;11(2):e0149527.","journal-title":"PLoS One"},{"key":"2058_CR40","first-page":"127","volume":"6","author":"SD Fenerty","year":"2012","unstructured":"Fenerty SD, et al. The effect of reminder systems on patients\u2019 adherence to treatment. Patient Prefer Adherence. 2012;6:127\u201335.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"2058_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/apc.2010.0006","volume":"25","author":"H Hardy","year":"2011","unstructured":"Hardy H, et al. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDs. 2011;25(3):153\u201361.","journal-title":"AIDS Patient Care STDs"},{"key":"2058_CR42","first-page":"45","volume":"4","author":"L Mbuagbaw","year":"2012","unstructured":"Mbuagbaw L, Bonono-Momnougui RC, Thabane L. Considerations in using text messages to improve adherence to highly active antiretroviral therapy: a qualitative study among clients in Yaounde, Cameroon. HIV\/AIDS (Auckl). 2012;4:45.","journal-title":"HIV\/AIDS (Auckl)"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-018-2058-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-018-2058-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-018-2058-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:44:59Z","timestamp":1775252699000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-018-2058-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1186\/s12884-018-2058-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study was approved by the Institutional Review Board of the University of Buea and the Ethics Committee at the University of Munich (LMU) in Germany. Administrative authorization to access health facilities within the health district was provided by the regional delegation of Public Health of the South West Region, Cameroon. Participation in the study was free and voluntary and only women who provided a written informed consent were enrolled into the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"418"}}